ContraFect Corporation (CFRX) held by 19 SEC 13F Filers

ContraFect Corporation (NASDAQ:CFRX) recovered 147.5% of its value since hitting low of $0.80. The recent move of -7.04% drop pushed the stock to close at $1.98 when trading ended on 03/13/2018. At recent session, the prices were hovering between $1.9 and $2.16. This company shares are 102.02% off its target price of $4 and the current market capitalization stands at $151.39M. The recent change has given its price a 37.27% lead over SMA 50 and -17.5% deficit over its 52-week high. The stock witnessed 36.08% gains, 120% gains and 105.03% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CFRX’s volatility during a week at 14.1% and during a month it has been found around 8.93%.

ContraFect Corporation (CFRX) Top Holders

Institutional investors currently hold around $97 million or 62.2% in CFRX stock. Look at its top three institutional owners. Fosun International Ltd owns $18.11 million in ContraFect Corporation, which represents roughly 11.96% of the company’s market cap and approximately 18.66% of the institutional ownership. Similar statistics are true for the second largest owner, Baker Bros. Advisors Lp, which owns 7,153,076 shares of the stock are valued at $15.24 million. The third largest holder is Federated Investors Inc /Pa/, which currently holds $12.78 million worth of this stock and that ownership represents nearly 8.44% of its market capitalization.

ContraFect Corporation 13F Filings

At the end of 12/31/2017 reporting period, 16 institutional holders increased their position in ContraFect Corporation (NASDAQ:CFRX) by some 1,538,412 shares, 10 decreased positions by 2,068,759 and 19 held positions by 41,871,202. That puts total institutional holdings at 45,478,373 shares, according to SEC filings. The stock grabbed 6 new institutional investments totaling 440,489 shares while 4 institutional investors sold out their entire positions totaling 217,734 shares.

ContraFect Corporation (NASDAQ:CFRX) Insider Trades

Multiple company employees have indulged in significant insider trading. ContraFect Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Blech Isaac has acquired 16,000 shares of ContraFect Corporation (CFRX) in trading session dated Jul. 25, 2017. These shares are worth $19,840 and were traded at $1.24 each. The SEC filing shows that Gilman Steven C performed a purchase of 800 shares. The CEO added these shares by way of transaction on Jul. 25, 2017. The company’s shares were assimilated at $1.24 per share worth to an investment of some $992 on account of Gilman Steven C.

Director, Barer Sol J, purchased 40,000 common shares of ContraFect Corporation (CFRX) in the open market. In a transaction dated Jul. 25, 2017, the shares were bought at an average price of $1.24, giving away a sum of $49,600. After this purchase, 815,933 common shares of CFRX are directly owned by the insider, with total stake valued at $1,615,547.

In the transaction dated Jul. 25, 2017, the great number of shares acquired came courtesy the Director; Low David N. added a total of 40,000 shares at an average price of $1.24, amounting to approximately $49,600. The insider now directly owns 70,550 shares worth $139,689.

ContraFect Corporation (CFRX) Analyst Guide

Several analysts have released their opinion on ContraFect Corporation (NASDAQ:CFRX), with 2 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.67 average brokerage recommendation.

Previous articleTabula Rasa Healthcare, Inc. (TRHC): A Detailed Look at its Institutional Ownership
Next article24 hedge funds buy Accelerate Diagnostics, Inc. (AXDX) for the first time